The NGS workflow was retrospectively evaluated on DNA extracted from SF and matching FFPE and cfDNA belonging to 12 resected NSCLC patients previously tested for EGFR and KRAS mutations by SS. This evidence concerns the gene EGFR and non-small cell lung carcinoma.